[哪种肥大细胞抑制剂用于眼科?]。

P Vérin, H Andrianjafy, J de Casamayor, D Fritsch
{"title":"[哪种肥大细胞抑制剂用于眼科?]。","authors":"P Vérin,&nbsp;H Andrianjafy,&nbsp;J de Casamayor,&nbsp;D Fritsch","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Correct treatment of allergic conjunctivitis cannot be achieved bay simple classification into two categories, i.E. as perennial or seasonal conjunctivitis. It is important to distinguish the different forms, each of which have a different pathogenicity and a different treatment. Opticron is the reference product. All others drugs must be evaluated by randomized double-masked studies.</p>","PeriodicalId":9346,"journal":{"name":"Bulletin des societes d'ophtalmologie de France","volume":"90 6-7","pages":"619-21"},"PeriodicalIF":0.0000,"publicationDate":"1990-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Which mast cell inhibition is to be used in ophthalmology?].\",\"authors\":\"P Vérin,&nbsp;H Andrianjafy,&nbsp;J de Casamayor,&nbsp;D Fritsch\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Correct treatment of allergic conjunctivitis cannot be achieved bay simple classification into two categories, i.E. as perennial or seasonal conjunctivitis. It is important to distinguish the different forms, each of which have a different pathogenicity and a different treatment. Opticron is the reference product. All others drugs must be evaluated by randomized double-masked studies.</p>\",\"PeriodicalId\":9346,\"journal\":{\"name\":\"Bulletin des societes d'ophtalmologie de France\",\"volume\":\"90 6-7\",\"pages\":\"619-21\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1990-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bulletin des societes d'ophtalmologie de France\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin des societes d'ophtalmologie de France","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

正确治疗过敏性结膜炎不能达到简单的两类分类,即常年性结膜炎或季节性结膜炎。重要的是要区分不同的形式,每一种都有不同的致病性和不同的治疗方法。Opticron是参考产品。所有其他药物必须通过随机双盲研究进行评估。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
[Which mast cell inhibition is to be used in ophthalmology?].

Correct treatment of allergic conjunctivitis cannot be achieved bay simple classification into two categories, i.E. as perennial or seasonal conjunctivitis. It is important to distinguish the different forms, each of which have a different pathogenicity and a different treatment. Opticron is the reference product. All others drugs must be evaluated by randomized double-masked studies.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信